- Conditions
- Spine Metastases
- Interventions
- Prophylactic Radiotherapy, Standard of care systemic therapy
- Radiation · Drug
- Lead sponsor
- Baptist Health South Florida
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 74 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 1
- States / cities
- Miami, Florida
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 252
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Hematuria, Urothelial Carcinoma
- Interventions
- Cxbladder
- Diagnostic Test
- Lead sponsor
- Pacific Edge Limited
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 554 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2024
- U.S. locations
- 10
- States / cities
- Los Angeles, California • Winter Garden, Florida • Chicago, Illinois + 6 more
- Conditions
- Lung Cancers
- Interventions
- Not listed
- Lead sponsor
- Everest Detection, Inc.
- Industry
- Eligibility
- 30 Years to 80 Years
- Enrollment
- 350 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2029
- U.S. locations
- 1
- States / cities
- Oklahoma City, Oklahoma
- Conditions
- Asthma
- Interventions
- RG1671
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 43 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 8
- States / cities
- Little Rock, Arkansas • North Hollywood, California • Port Orange, Florida + 5 more
- Conditions
- Diabetes Mellitus, Type 2, Coronary Restenosis
- Interventions
- Technetium Tc99m Sestamibi
- Drug
- Lead sponsor
- Lantheus Medical Imaging
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 106 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2005
- U.S. locations
- 7
- States / cities
- Hartford, Connecticut • Waterbury, Connecticut • Grand Rapids, Michigan + 4 more
- Conditions
- HIV Infections
- Interventions
- Interleukin-2, Polyethylene Glycolated, Zidovudine, Didanosine
- Drug
- Lead sponsor
- Chiron Corporation
- Industry
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Constipation
- Interventions
- lubiprostone, placebo
- Drug
- Lead sponsor
- Texas Tech University Health Sciences Center, El Paso
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 40 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2011 – 2012
- U.S. locations
- 1
- States / cities
- El Paso, Texas
- Conditions
- Breast Cancer, Tumors, Breast
- Interventions
- DBT and FFDM
- Device
- Lead sponsor
- GE Healthcare
- Industry
- Eligibility
- 30 Years and older · Female only
- Enrollment
- 94 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 2
- States / cities
- Greenville, North Carolina • Sioux Falls, South Dakota
- Conditions
- Asymptomatic Condition
- Interventions
- Inferior glide humerus in GH joint
- Procedure
- Lead sponsor
- Dr. Rob Sillevis,
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 64 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Fort Myers, Florida
- Conditions
- Congenital Cytomegalovirus Infection
- Interventions
- Valganciclovir
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 1 Day to 30 Days
- Enrollment
- 7 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 9
- States / cities
- Birmingham, Alabama • Little Rock, Arkansas • Louisville, Kentucky + 6 more
- Conditions
- Breast Cancer, Breast Neoplasms
- Interventions
- Reading of Automated Breast Ultrasound in conjunction with Screening Mammography
- Device
- Lead sponsor
- Delphinus Medical Technologies, Inc.
- Industry
- Eligibility
- Not listed
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Ovarian Cancer, Primary Peritoneal Carcinoma
- Interventions
- Å6 subcutaneous injection
- Drug
- Lead sponsor
- Ångstrom Pharmaceuticals
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2006
- U.S. locations
- 24
- States / cities
- Birmingham, Alabama • Casa Grande, Arizona • Fresno, California + 21 more
- Conditions
- Esophageal Cancer
- Interventions
- Not listed
- Lead sponsor
- University of California, Davis
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 19 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 1
- States / cities
- Sacramento, California
- Conditions
- Carotid Artery Stenosis, Strokes
- Interventions
- Statin, Atorvastatin, Placebo
- Drug · Other
- Lead sponsor
- Columbia University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 31 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2020
- U.S. locations
- 7
- States / cities
- Ridgewood, New Jersey • Albany, New York • Buffalo, New York + 1 more
- Conditions
- Multiple Myeloma
- Interventions
- Zoledronic Acid
- Drug
- Lead sponsor
- Hoosier Cancer Research Network
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 3 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 8
- States / cities
- Elkhart, Indiana • Evansville, Indiana • Indianapolis, Indiana + 3 more
- Conditions
- Cardiovascular Disease
- Interventions
- Not listed
- Lead sponsor
- Baptist Health South Florida
- Other
- Eligibility
- 40 Years to 65 Years
- Enrollment
- 4,000 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2028
- U.S. locations
- 1
- States / cities
- Miami, Florida
- Conditions
- Prostate Cancer
- Interventions
- lycopene
- Dietary Supplement
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 47 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2009
- U.S. locations
- 18
- States / cities
- Scottsdale, Arizona • Jacksonville, Florida • Atlanta, Georgia + 15 more
- Conditions
- HIV Infections
- Interventions
- gp160 Vaccine (Immuno-AG), Hepatitis B Vaccine (Recombinant)
- Biological
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 55 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Ends 1998
- U.S. locations
- 2
- States / cities
- Baltimore, Maryland • St Louis, Missouri
- Conditions
- Leukemia
- Interventions
- Polyphenon E
- Biological
- Lead sponsor
- Mayo Clinic
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 73 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2012
- U.S. locations
- 2
- States / cities
- Scottsdale, Arizona • Rochester, Minnesota
- Conditions
- Prostate Cancer
- Interventions
- docetaxel, estramustine phosphate sodium, ketoconazole, therapeutic hydrocortisone
- Drug
- Lead sponsor
- Eastern Cooperative Oncology Group
- Network
- Eligibility
- 18 Years to 120 Years · Male only
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2003
- U.S. locations
- 98
- States / cities
- Huntsville, Alabama • Scottsdale, Arizona • Tucson, Arizona + 76 more
- Conditions
- Cancer, Ovarian Cancer
- Interventions
- BBI503
- Drug
- Lead sponsor
- Sumitomo Pharma America, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 13 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 1
- States / cities
- Rochester, Minnesota
- Conditions
- Bacteriuria, Urinary Tract Infections, Asymptomatic Infections, Transplantation Infection
- Interventions
- Antibiotic
- Drug
- Lead sponsor
- Rice, James C., M.D.
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2013
- U.S. locations
- 1
- States / cities
- La Jolla, California
- Conditions
- Lymphoplasmacytic Lymphoma
- Interventions
- Autologous Lymphoma Immunoglobulin-derived scFv-chemokine DNA Vaccine, Laboratory Biomarker Analysis
- Biological · Other
- Lead sponsor
- M.D. Anderson Cancer Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 9 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2025
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- HIV Infections
- Interventions
- KD-247, Physiological saline
- Drug
- Lead sponsor
- The Chemo-Sero-Therapeutic Research Institute
- Industry
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 27 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2007
- U.S. locations
- 15
- States / cities
- Beverly Hills, California • Burbank, California • Los Angeles, California + 12 more